Your browser doesn't support javascript.
loading
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine.
Puledda, Francesca; Sacco, Simona; Diener, Hans-Christoph; Ashina, Messoud; Al-Khazali, Haidar M; Ashina, Sait; Burstein, Rami; Liebler, Eric; Cipriani, Andrea; Chu, Min Kyung; Cocores, Alexandra; Dodd-Glover, Freda; Ekizoglu, Esme; Garcia-Azorin, David; Göbel, Carl; Goicochea, Maria Teresa; Hassan, Amr; Hirata, Koichi; Hoffmann, Jan; Jenkins, Bronwyn; Kamm, Katharina; Lee, Mi Ji; Ling, Yu-Hsiang; Lisicki, Marco; Martinelli, Daniele; Monteith, Teshamae S; Ornello, Raffaele; Ozge, Aynur; Peres, Mario; Pozo-Rosich, Patricia; Romanenko, Volodymyr; Schwedt, Todd J; Souza, Marcio Nattan P; Takizawa, Tsubasa; Terwindt, Gisela M; Thuraiaiyah, Janu; Togha, Mansoureh; Vandenbussche, Nicolas; Wang, Shuu-Jiun; Yu, Shengyuan; Tassorelli, Cristina.
Affiliation
  • Puledda F; Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Sacco S; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Diener HC; Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology, Faculty of Medicine, University Duisburg-Essen, Essen, Germany.
  • Ashina M; Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Al-Khazali HM; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Ashina S; Department of Neurology, Danish Headache Center, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Burstein R; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Liebler E; Department of Neurology and Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, USA.
  • Cipriani A; Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA.
  • Chu MK; International Headache Society, London, UK.
  • Cocores A; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Dodd-Glover F; Oxford Precision Psychiatry Lab, NIHR Oxford Health Biomedical Research Centre, Oxford, UK.
  • Ekizoglu E; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.
  • Garcia-Azorin D; Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Göbel C; Department of Neurology - Headache Division, University of Miami, Miller School of Medicine, Miami, USA.
  • Goicochea MT; Department of Medicine and Therapeutics, Korle Bu Teaching Hospital, Accra, Ghana.
  • Hassan A; Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
  • Hirata K; Headache Unit, Department of Neurology, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.
  • Hoffmann J; Kiel Migraine and Headache Centre, Kiel, Germany.
  • Jenkins B; Department of Neurology, Christian-Albrechts University, Kiel, Germany.
  • Kamm K; Neurology Department, Headache Clinic, Fleni, Buenos Aires, Argentina.
  • Lee MJ; Department of Neurology, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Ling YH; Neurology, Dokkyo Medical University, Mibu, Tochigi, Japan.
  • Lisicki M; Wolfson Sensory, Pain and Regeneration Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
  • Martinelli D; Royal North Shore Hospital, St Leonards, Sydney, Australia.
  • Monteith TS; Department of Neurology, Klinikum der Universitat Munchen, Munich, Germany.
  • Ornello R; Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Ozge A; Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Peres M; Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Córdoba, Córdoba, Argentina.
  • Pozo-Rosich P; Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Universidad Nacional de Córdoba, Córdoba, Argentina.
  • Romanenko V; IRCCS Mondino Foundation, Headache Science Center, Pavia, Italy.
  • Schwedt TJ; Department of Neurology - Headache Division, University of Miami, Miller School of Medicine, Miami, USA.
  • Souza MNP; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Takizawa T; Mersin University School of Medicine, Mersin, Turkey.
  • Terwindt GM; Institute of Psychiatry, HCFMUSP, Sao Paulo, Brazil.
  • Thuraiaiyah J; Headache Unit, Neurology Department, Hospital Universitari Vall d'Hebron and Headache & Neurological Pain Research Group, Vall d'Hebron Institute of Research, Barcelona, Spain.
  • Togha M; Vita Medical Center, Kyiv, Ukraine.
  • Vandenbussche N; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
  • Wang SJ; Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil.
  • Yu S; Department of Neurology, Keio University School of Medicine, Tokyo, Japan.
  • Tassorelli C; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Cephalalgia ; 44(8): 3331024241252666, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39133176
ABSTRACT

BACKGROUND:

In an effort to improve migraine management around the world, the International Headache Society (IHS) has here developed a list of practical recommendations for the acute pharmacological treatment of migraine. The recommendations are categorized into optimal and essential, in order to provide treatment options for all possible settings, including those with limited access to migraine medications.

METHODS:

An IHS steering committee developed a list of clinical questions based on practical issues in the management of migraine. A selected group of international senior and junior headache experts developed the recommendations, following expert consensus and the review of available national and international headache guidelines and guidance documents. Following the initial search, a bibliography of twenty-one national and international guidelines was created and reviewed by the working group.

RESULTS:

A total of seventeen questions addressing different aspects of acute migraine treatment have been outlined. For each of them we provide an optimal recommendation, to be used whenever possible, and an essential recommendation to be used when the optimal level cannot be attained.

CONCLUSION:

Adoption of these international recommendations will improve the quality of acute migraine treatment around the world, even where pharmacological options remain limited.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Migraine Disorders Limits: Humans Language: En Journal: Cephalalgia Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Migraine Disorders Limits: Humans Language: En Journal: Cephalalgia Year: 2024 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom